During the past decade, Xenoscience Inc. conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 12 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Xenoscience Inc." #1 sponsor was "Allergan" with 2 trials, followed by "Biogen" with 2 trials sponsored, "Celgene" with 2 trials sponsored, "Chelsea Therapeutics" with 2 trials sponsored and "Navidea Biopharmaceuticals" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Xenoscience Inc." #1 collaborator was "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator, "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Xenoscience Inc." are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (3 trials), "Dopamine Beta Hydroxylase Deficiency" (2 trials), "Migraine, With or Without Aura" (2 trials) and "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Xenoscience Inc." in a lesser frequency.

Most popular intervention types in "Xenoscience Inc." are "Drug" (25 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Droxidopa" (2 trials), "NAV5001" (2 trials), "Placebo-matching Ubrogepant" (2 trials) and "Ubrogepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Xenoscience Inc." are 25 trials for "All" genders.

Currently, there are NaN active trials in "Xenoscience Inc.". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Xenoscience Inc., undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Xenoscience Inc., 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".